AngioDynamics Stock Plunges 13.8% in Three Months: What's Next?

AngioDynamics, Inc.'s (ANGO) investors have been experiencing some short-term losses from the stock of late. Shares of the Latham, NY-based medical technology company have plunged 13.8% in the past three months, underperforming the industry's 0.3% gain. In the same time frame, the stock underperformed the sector's decline of 2.2% and the S&P 500's 6.9% growth. Two major developments from ANGO this month include the announcement of its first-quarter fiscal 2025 results and the grant of Category I CPT for Irr ...